Sichenzia Ross Ference LLP Represents Genetic Technologies in a $5 Million Registered Direct Offering 

Press Release – New York, NY – February 9, 2023 – Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (the “Company”) (ASX:GTG, NASDAQ: GENE), a global leader in guideline-driven genomics-based tests in health, wellness, and serious diseases, in a $5 million registered direct offering of American Depositary Shares (“ADSs”). The registered direct offering consisted of 2,307,693,000 ordinary shares represented by 3,846,155 ADSs at an offering price of $1.30 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Matthew Siracusa.